S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
OTCMKTS:EVTCY

Evotec (EVTCY) Stock Price, News & Analysis

$7.15
-0.09 (-1.24%)
(As of 04/18/2024 ET)
Today's Range
$6.98
$7.19
50-Day Range
$6.89
$7.87
52-Week Range
$14.22
$26.57
Volume
27,408 shs
Average Volume
2,407 shs
Market Capitalization
$2.36 billion
P/E Ratio
17.66
Dividend Yield
N/A
Price Target
N/A
EVTCY stock logo

About Evotec Stock (OTCMKTS:EVTCY)

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties. The EVT Innovate develops drug discovery projects, assets and platforms, both internally or through academic collaborations. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, and Charles Weissmann on December 8, 1993 and is headquartered in Hamburg, Germany.

EVTCY Stock Price History

EVTCY Stock News Headlines

Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Evotec SE (NASDAQ:EVO) Q3 2023 Earnings Call Transcript
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Is There Now An Opportunity In Evotec SE (ETR:EVT)?
Evotec SE ADR (EVO) Earnings Dates & Reports
Evotec SE ADR (EVO)
Evotec SE Provides Update on Cyber Attack
See More Headlines
Receive EVTCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evotec and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/18/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:EVTCY
Employees
3,572
Year Founded
1993

Profitability

Net Income
$7.14 million
Pretax Margin
23.90%

Debt

Sales & Book Value

Annual Sales
$572.16 million
Cash Flow
$0.07 per share
Book Value
$2.52 per share

Miscellaneous

Free Float
N/A
Market Cap
$2.36 billion
Optionable
Not Optionable
Beta
0.98

Social Links

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Werner Lanthaler
    Chief Executive Officer
  • Craig L. Johnstone
    Chief Operating Officer & Member-Management Board
  • Enno Spillner
    Chief Financial Officer
  • Cord E. Dohrmann
    Chief Scientific Officer
  • Volker Braun
    SVP, Head-Investor Relations & ESG

EVTCY Stock Analysis - Frequently Asked Questions

How have EVTCY shares performed in 2024?

Evotec's stock was trading at $11.73 on January 1st, 2024. Since then, EVTCY stock has decreased by 39.0% and is now trading at $7.15.
View the best growth stocks for 2024 here
.

When did Evotec's stock split?

Evotec's stock split on Wednesday, October 20th 2021. The 3-1 split was announced on Wednesday, October 20th 2021. The newly created shares were payable to shareholders after the market closes on Wednesday, October 20th 2021. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.

How do I buy shares of Evotec?

Shares of EVTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Evotec have any subsidiaries?
The following companies are subsidiares of Evotec: Aptuit, Bionamics GmbH, Cell Culture Service GmbH, Central Glass Germany, Central Glass Germany. GmbH, Compound Focus, Cyprotex, Develogen AG, Euprotec, Evotec (India) Private Ltd, GlaxoSmithKine's the Verona site, Just-Evotec Biologics, KINAXO Biotechnologies, Oxford Asymmetry International, RENOVIS, and Rigenerand Srl.
Read More
This page (OTCMKTS:EVTCY) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners